Sonar’s New, Powerful Deep-Analysis Capability Finds Hidden Code Level Security Issues
2.8.2023 16:00:00 EEST | Business Wire | Press release
Sonar, the leading Clean Code solution provider, today announced a significant advancement of its Clean Code offering – developers can now automatically discover and fix code security issues arising from interactions between user source code and third-party, open-source libraries.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230802497889/en/
Sonar deeper SAST finds hidden code level security issues (Graphic: Business Wire)
Referred to as deeper SAST, the new advanced detection addresses issues that traditional SAST tools miss by not following the flow within library code. Traditional SAST vendors analyze user application code. These tools do not scan the combined code, and flag libraries in an unsophisticated way, ignoring the context and use within the library. The result is that library features are considered black boxes, leaving organizations in the dark about whether they're truly secure for a given context or not. Moreover, these tools typically support only a handful of popular frameworks, often requiring up-front configurations for setup. All of this leads to the security issues created by the unique usage of third-party open source libraries going undetected.
“Code is code, whether it is written by a developer in your team or whether it comes as part of a library that is solving a specific problem. The two different approaches always bothered me, and I am thrilled that we are now able to analyze all codes the same way at once, solving what was considered an impossible problem,” said Olivier Gaudin, CEO and co-founder of Sonar. “With the deeper SAST advancements made to our Clean Code solution, organizations can discover these vulnerabilities and resolve them quickly as code is developed.”
Sonar addresses the gap of traditional SAST through its fine-grained analysis of user source code interactions with external dependencies, all without the need for any special configuration or incremental costs. This deeper SAST innovation furthers Sonar’s mission to equip organizations to achieve a state of Clean Code — code that is consistent, intentional, adaptable, and responsible. When code adheres to these characteristics, software becomes reliable, maintainable, and secure.
“It’s estimated that over 90% of applications leverage third-party libraries and interact with the code within them, but most SAST tools don’t tell developers which dependencies make their code vulnerable. Security is mission-critical, and the more issues you find and fix before they have the ability to cause you harm, the better off your business will be,” said Rik Turner, a Senior Principal Analyst covering cybersecurity at Omdia. “This is the essence of the proactive security wave we are seeing across the cyber sector: find it and fix it before it’s exploited.”
Sonar deeper SAST functionality is available at no additional cost within commercial editions of SonarQube (self-managed) and SonarCloud (cloud-based) — industry-leading static analysis code review tools that continuously inspect and analyze the codebase using quality gates to determine if code meets the defined standards for development and production. Deeper SAST currently supports Java, C#, and TypeScript programming languages and covers thousands of the topmost and commonly used open-source libraries, including their subsequent (transitive) dependencies.
Achieving a Clean Code State
Sonar empowers development teams to write Clean Code by providing them with the right tools and best practices, so they can spend less time fixing issues and more time meeting delivery and business goals. Pairing the Sonar solution with the company’s Clean as You Code methodology — set standards for keeping new, added, or edited code clean — and its educational guidance for code called ‘Learn as You Code,’ developers have faster issue remediation and delivery, code enhancement, and can further professional growth and team retention. Today, there are over seven million developers using Sonar.
Sonar also actively engages with its ecosystem and customer communities, in addition to partnerships with several universities for security research projects, and the open source software and start-up communities. Additionally, Sonar has a dedicated team of security researchers that find and responsibly disclose exploitable zero-day vulnerabilities in open-source software; these findings are used as inspiration for new security rules and detections to help find vulnerabilities.
Learn more about our deeper SAST innovation and Sonar solution (SonarQube, SonarCloud, SonarLint). Meet Sonar experts at Black Hat USA, booth #2760, August 8-10.
About Sonar
Sonar empowers developers and organizations to systematically achieve a state of Clean Code so that all code is fit for development and production. By applying the Sonar Clean as You Code methodology, organizations minimize risk, reduce technical debt, and derive more value from their software in a predictable and sustainable way.
The open source and commercial Sonar solution – SonarLint, SonarCloud, and SonarQube – supports over 30 programming languages, frameworks, and infrastructure technologies. Trusted by more than 400,000 organizations globally to clean more than half a trillion lines of code, Sonar is integral to delivering better software.
To learn more about Sonar, please visit https://www.sonarsource.com/company/about/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230802497889/en/
Contact information
Katie Hyman
Senior PR Manager, Sonar
katie.hyman@sonarsource.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
